Professional Guidance: Which Treatment Suits You?
What's Best Mounjaro or Wegovy: Understanding Key Differences for UK Buyers
When determining what's best between Mounjaro or Wegovy, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, whilst Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors for dual hormone regulation. This dual mechanism may offer different appetite control profiles, though both are prescription-only medicines requiring clinical assessment. Your individual medical history, current medications, and treatment goals will influence which option your prescriber recommends.
For UK buyers seeking convenience, both treatments are available through our regulated online service with identical assessment processes. The choice between what's best Mounjaro or Wegovy often depends on factors like dosing frequency, storage requirements, and individual response patterns. Our prescribers evaluate your complete medical profile during the clinical assessment, ensuring the selected treatment aligns with NICE guidelines and your specific circumstances for optimal weight management outcomes.
Wegovy Pricing and Value: Transparent UK Costs
Understanding the financial commitment helps determine what's best between Mounjaro or Wegovy for your budget. Wegovy pricing starts at £79.99 for the 0.25mg starter dose (weeks 1-4), progressing through £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to reach these final prices. Bundle options like our Intro Duo (0.25mg & 0.5mg) cost £169.99, providing convenient dual-month supply with Confirmed Availability.
Our pricing structure reflects genuine Novo Nordisk Wegovy sourced through regulated UK pharmaceutical channels, ensuring product authenticity and cold-chain integrity. When comparing what's best Mounjaro or Wegovy financially, consider the complete treatment journey including assessment fees, delivery costs, and ongoing prescriber support. Our transparent pricing includes clinical assessment, prescriber review, and next-day temperature-controlled delivery, with no hidden fees or subscription commitments beyond your chosen treatment duration.
Clinical Evidence: What Research Shows About Effectiveness
Clinical trials provide objective data when evaluating what's best between Mounjaro or Wegovy. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained 15.2% weight reduction at two years, whilst the SELECT cardiovascular outcomes study showed 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials demonstrated different efficacy profiles, though direct comparison between trials isn't appropriate due to varying study designs and patient populations. Both treatments work as prescription-only medicines alongside reduced-calorie diet and increased physical activity, with individual responses varying significantly. Your prescriber will discuss relevant clinical evidence during assessment, helping determine which treatment profile aligns with your medical history and weight management goals.
How Wegovy Works: GLP-1 Mechanism Explained
Wegovy functions as a GLP-1 receptor agonist, mimicking incretin hormones naturally produced in your intestines after eating. This mechanism reduces appetite by signalling fullness to brain appetite centres, promoting satiety after smaller meal portions and potentially reducing food cravings throughout the day. The once-weekly injection maintains steady hormone levels, supporting consistent appetite regulation compared to daily medications that may cause fluctuating effects. Wegovy also slows gastric emptying, helping food remain in your stomach longer and extending feelings of fullness between meals. This comprehensive approach to appetite control makes Wegovy effective for long-term weight management when combined with lifestyle modifications as recommended by NICE guidelines.
Simple Ordering Process: Assessment to Delivery
Our streamlined process makes accessing either treatment straightforward when deciding what's best Mounjaro or Wegovy for your needs. Begin with our 3-minute online clinical assessment covering medical history, current medications, previous weight management attempts, and treatment preferences to help prescribers make informed recommendations. Standard prescriber review takes 3 working days, though express 24-hour review is available for faster treatment initiation when clinically appropriate. Once approved, genuine medication dispatches via next-day delivery using temperature-controlled cold-chain logistics to maintain product integrity. Our GPhC-registered pharmacy (#9012878) ensures full regulatory compliance throughout the supply chain. Customer support remains available throughout your treatment journey, with prescriber consultations accessible for ongoing medication management and dosage adjustments.
Storage and Practical Considerations
Practical factors often influence what's best between Mounjaro or Wegovy for individual lifestyles. Wegovy requires refrigeration at 2-8°C before first use but offers superior travel flexibility, remaining stable for 6 weeks at room temperature below 30°C once removed from refrigeration compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen delivery system provides pre-measured doses with simple injection technique suitable for self-administration after proper training. Dose escalation follows a mandatory schedule starting at 0.25mg weekly, increasing monthly through 0.5mg, 1mg, 1.7mg, reaching 2.4mg maintenance dose at week 17 to minimise gastrointestinal side effects. Weekly injection timing remains flexible, though consistency within 2-3 days helps maintain steady hormone levels. Proper needle disposal using provided sharps containers ensures safe medication handling throughout treatment duration.
What's Best Mounjaro or Wegovy: Personalised Treatment Selection
Determining what's best between Mounjaro or Wegovy requires individualised assessment considering medical history, concurrent medications, lifestyle factors, and treatment preferences. Patients with certain medical conditions may be better suited to one treatment over another based on contraindication profiles and drug interaction potentials. Your prescriber evaluates these factors during clinical assessment, ensuring selected treatment aligns with current NICE guidelines and MHRA licensing requirements for safe, effective weight management.
Both treatments represent significant advances in obesity medicine, offering different approaches to appetite regulation and weight control. Rather than determining what's best Mounjaro or Wegovy universally, our approach focuses on what's best for your individual circumstances through comprehensive prescriber evaluation. This personalised selection process, combined with ongoing clinical support and monitoring, optimises treatment outcomes whilst minimising potential adverse effects throughout your weight management journey.
Start Your Treatment: Codes and Ordering
Ready to begin your weight management journey after determining what's best Mounjaro or Wegovy for your needs? New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access our competitive pricing structure starting from £79.99. Our clinical assessment takes just 3 minutes to complete, covering essential medical information needed for prescriber review and treatment recommendation. Express prescriber review ensures faster treatment initiation when appropriate, with next-day delivery maintaining cold-chain integrity for optimal medication effectiveness. Visit our Wegovy collection at https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today. Both Wegovy and Mounjaro remain available through our regulated service, with prescriber guidance ensuring you receive the most suitable treatment for sustainable weight management success.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
